The Narcotic Bowel Syndrome: Clinical Features, Pathophysiology, and Management
- 31 October 2007
- journal article
- case report
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 5 (10), 1126-1139
- https://doi.org/10.1016/j.cgh.2007.06.013
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Abstract A25: Public and provider awareness and use of a CA-125 test for ovarian cancerCancer Prevention Research, 2010
- Microglia: a newly discovered role in visceral hypersensitivity?Neuron Glia Biology, 2006
- Alvimopan, a selective peripherally acting μ‐opioid antagonist*Neurogastroenterology & Motility, 2005
- Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field ExperienceThe American Journal on Addictions, 2004
- Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and NaloxoneThe New England Journal of Medicine, 2003
- Opioid-Induced Bowel DysfunctionDrugs, 2003
- Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liabilityPain, 2000
- The Opioid-Sparing Effects of Intravenous Ketorolac as an Adjuvant Analgesic in Cancer Pain: Application in Bone Metastases and the Opioid Bowel SyndromeJournal of Pain and Symptom Management, 1998
- Randomised trial of oral morphine for chronic non-cancer painThe Lancet, 1996
- Self-efficacy and the stages of self-change of smokingCognitive Therapy and Research, 1985